Linfogammagrafía de miembros inferiores: tres posibles patrones / Lower-limb lymphoscintigraphy: three possible patterns

Una de las múltiples causas del edema de miembros inferiores es el linfedema cuyo diagnóstico correcto es crucial para la precoz instauración de un tratamiento efectivo y evitar así la morbilidad que este ocasiona a los pacientes. Desde la perspectiva del médico nuclear presentamos tres casos de edema de miembros inferiores. Tras una breve descripción de la técnica empleada y del mecanismo de actuación del radioisótopo (nanocoloides de albúmina humana marcados con Tc-99m) describimos el patrón de captación de la linfogammagrafía de miembros inferiores en pacientes seleccionados, por ser cada uno de ellos representativos de lo que en diagnóstico de imagen nuclear se considera normal, linfedema primario y linfedema secundario (AU)

One of many causes of lower-limb oedema is lymphedema. Correct diagnosis of this entity is crucial for the early establishment of an effective treatment to avoid the morbidity caused to the patient. From the perspective of nuclear medicine physicians, we present three cases of lower-limb oedema. After providing a brief description of the technique used and the mechanism of action of radioisotope (Tc-99m-labelled human albumin nanocolloid), we describe the uptake pattern of lower-limb lymphoscintigraphy in three representative cases of what is considered normal, primary lymphedema and secondary lymphedema (AU)

Un caso infrecuente de doble adenoma paratiroideo evidenciado con 99mTc-sestaMIBI SPECT/TC / A rare case of double parathyroid adenoma evidenced by 99mTc-sestaMIBI SPECT/CT

No disponible

Evaluación longitudinal con FP-CIT en pacientes con parkinsonismo / Longitudinal evaluation using FP-CIT in patients with parkinsonism

Objetivo: Analizar un grupo de pacientes con síndrome parkinsoniano mediante estudios seriados con FP-CIT, valorando fundamentalmente los resultados falsamente negativos iniciales. Métodos: Estudio retrospectivo en el que se incluye a 92 pacientes (55 varones y 37 mujeres), a los que se les realizó un doble estudio con FP-CIT pues existían discrepancias entre este y la evolución clínica del paciente. El tiempo medio ± desviación estándar transcurrido entre ambos estudios fue de 26 ± 6 meses. Se realizó una valoración semicuantitativa analizando mediante la historia clínica y la bibliografía disponible los casos discrepantes con estudio inicial normal y posterior patológico. Resultados: Del total de 184 estudios realizados a 92 pacientes, 11/92 mostraron resultados discrepantes entre estudio inicial y tardío. De estos, en 7/11 el estudio inicial fue normal y el posterior patológico. Los rasgos clínicos predominantes que pudieran explicar este comportamiento mostraron que en 4/7 sujetos destacó la presentación de un cuadro parkinsoniano con predominio de la clínica tremórica; 1/7 presentó un síndrome parkinsoniano en estadio inicial en tratamiento con fármaco antidopaminérgico, 1/7 fue catalogado de probable atrofia multisistema tipo C y 1/7 presentaba un cuadro de parkinsonismo atípico, sin que encontráramos justificación para dicho comportamiento. Conclusiones: La realización de estudios seriados con FP-CIT carece de fundamento en gran proporción de casos, aunque existen ciertas situaciones clínicas que pueden justificarlo

Objective: To assess a group of patients with parkinsonism using serial studies with FP-CIT, basically the initial false negative results. Methods: Restrospective study of 92 patients (55 men and 37 women) who had undergone 2 different FP-CIT studies because of discrepancies between study results and clinical progression. The mean elapsed time between the studies was 26 months (SD: 6). We performed a semi-quantitative study using the patient's clinical history and the available literature to analyse discrepant cases with a normal initial study and subsequent pathological findings. Results: A total of 184 studies were completed for 92 patients; 11 of those 92 showed discrepancies between initial and subsequent studies. Among the 11 discrepant cases, 7 showed a normal initial study and pathological findings at a later date. Analysis of the predominant clinical features that might explain this behaviour revealed that 4 of these 7 subjects presented tremor-dominant parkinsonism. Regarding the rest, 1 presented early stage parkinsonism and was treated with antidopaminergic agents; 1 was classified as probable multisystem atrophy type C, and the third showed clinical signs of atypical parkinsonism without any causes of those signs being identified. Conclusions: Serial FP-CIT studies are unnecessary in the large majority of cases, but they may be justifiable in certain clinical situations

Longitudinal evaluation using FP-CIT in patients with parkinsonism.

OBJECTIVE: To assess a group of patients with parkinsonism using serial studies with FP-CIT, basically the initial false negative results. METHODS: Restrospective study of 92 patients (55 men and 37 women) who had undergone 2 different FP-CIT studies because of discrepancies between study results and clinical progression. The mean elapsed time between the studies was 26 months (SD: 6). We performed a semi-quantitative study using the patient's clinical history and the available literature to analyse discrepant cases with a normal initial study and subsequent pathological findings. RESULTS: A total of 184 studies were completed for 92 patients; 11 of those 92 showed discrepancies between initial and subsequent studies. Among the 11 discrepant cases, 7 showed a normal initial study and pathological findings at a later date. Analysis of the predominant clinical features that might explain this behaviour revealed that 4 of these 7 subjects presented tremor-dominant parkinsonism. Regarding the rest, 1 presented early stage parkinsonism and was treated with antidopaminergic agents; 1 was classified as probable multisystem atrophy type C, and the third showed clinical signs of atypical parkinsonism without any causes of those signs being identified. CONCLUSIONS: Serial FP-CIT studies are unnecessary in the large majority of cases, but they may be justifiable in certain clinical situations.

Valoración cuantitativa del SPECT con FP-CIT. Importancia del área de referencia / Quantitative evaluation of SPECT with FP-CIT. Importance of the reference area

Objetivo. El objetivo del presente estudio es comparar diversos índices de captación entre actividad específica/inespecífica para determinar la existencia de parkinsonismo degenerativo teniendo en cuenta diferentes áreas de referencia. Material y métodos. Se incluyen a 46 pacientes (23 hombres y 23 mujeres) seleccionados de forma aleatoria de los sujetos remitidos a nuestro centro por presentar un trastorno del movimiento. La edad media de los mismos fue de 70,2±10,2 años (41–87). Los índices de captación se realizan mediante ROI localizadas en estriados (captación específica) y otras de referencia situadas en zonas con baja concentración de receptores serotoninérgicos (cerebelo), media (corteza occipital) y alta (mesencéfalo). Resultado. Se aprecia una elevada correlación entre índices con baja y media concentración de receptores serotoninérgicos. El análisis mediante curvas ROC muestra un área bajo la curva de 0,874, 0,886 y 0,739 y unos coeficientes de regresión de 5,41, 6,62 y 3,41 respectivamente para los índices estriado/cerebelo (E/C), estriado/occipital (E/O) y estriado/mesencéfalo (E/M). El punto de corte óptimo para el estriado/occipital (1,35), índice con mejor comportamiento, aporta una sensibilidad de 0,84 y una especificidad de 0,89. Conclusión. El área de referencia seleccionada, puede alterar la capacidad predictiva de los distintos índices a la hora de determinar la existencia de un parkinsonismo degenerativo(AU)

Objective. The aim of this study is to compare several uptake indexes between specific and non-specific activity to determine the existence of degenerative Parkinsonism according to different reference areas. Material and methods. A total of 46 patients (23 men and 23 women), randomly selected from individuals referred to our center with a movement disorder, were included in the study. Mean age was 70.2±10.2 years (41–87). The uptake indexes were obtained through the areas of interest (ROIs) located in the striate (specific uptake) and other reference ROIs located in areas with different concentrations of serotonin receptors: low-cerebellum, medium-occipital cortex and high-midbrain. Results. A high linear correlation was found between indexes having low and medium concentration of serotonin receptors. The ROC curve analysis shows an area under the curve of 0.874, 0.886 and 0.739 and regression coefficients of 5.41, 6.62 and 3.41, respectively for the striatum/cerebellum (E/C), striatum/occipital (E/O) and striatum midbrain (E/M) indexes. Optimal cutoff for E/O (1.35), index with the best behavior, provides a sensitivity of 0.84 and specificity of 0.89. Conclusion. The reference area selected may alter the predictive power of the different indexes to determine the existence of a degenerative Parkinsonism(AU)

[Quantitative evaluation of SPECT with FP-CIT. Importance of the reference area]. / Valoración cuantitativa del SPECT con FP-CIT. Importancia del área de referencia.

OBJECTIVE: The aim of this study is to compare several uptake indexes between specific and non-specific activity to determine the existence of degenerative Parkinsonism according to different reference areas. MATERIAL AND METHODS: A total of 46 patients (23 men and 23 women), randomly selected from individuals referred to our center with a movement disorder, were included in the study. Mean age was 70.2 ± 10.2 years (41-87). The uptake indexes were obtained through the areas of interest (ROIs) located in the striate (specific uptake) and other reference ROIs located in areas with different concentrations of serotonin receptors: low-cerebellum, medium-occipital cortex and high-midbrain. RESULTS: A high linear correlation was found between indexes having low and medium concentration of serotonin receptors. The ROC curve analysis shows an area under the curve of 0.874, 0.886 and 0.739 and regression coefficients of 5.41, 6.62 and 3.41, respectively for the striatum/cerebellum (E/C), striatum/occipital (E/O) and striatum midbrain (E/M) indexes. Optimal cutoff for E/O (1.35), index with the best behavior, provides a sensitivity of 0.84 and specificity of 0.89. CONCLUSION: The reference area selected may alter the predictive power of the different indexes to determine the existence of a degenerative Parkinsonism.

Utilidad de la PET/TAC para la caracterización del liposarcoma / CT-PET applicattion in the liposarcoma feature determination

No disponible

No disponible

[CT-PET application in the liposarcoma feature determination]. / Utilidad de la PET/TAC para la caracterización del liposarcoma.

The indication taken from the maximun tumor standarizad uptake (SUVmax) in soft tissue's cancer such as the liposarcomas leads to determine its methabolic behavicur and indicates the histologic subtype classification (myxoid).

Uso tutelado de la tomografía por emisión de positrones (PET): dificultades y controversias / Tutelage use of positron emission tomography (PET): difficulties and controversies

No disponible

No disponible

[Incidental diagnosis of medullary thyroid carcinoma (MTC) after performing 123I-metaiodobenzylguanidine (123I-MIBG) gammagraphy]. / Diagnóstico de carcinoma medular de tiroides (CMT) de forma casual tras realización de gammagrafía 123I-metayodobencilguanidina (123I-MIBG).

UNLABELLED: The objective of this clinical note is to emphasize diagnostic efficiency of 123I-MIBG scintigraphy in the initial diagnosis and follow-up of medullary thyroid carcinoma within MEN2. MATERIALS AND METHODS: We present the case of a patient who, during a scintigraphic study with 123I-MIBG for the diagnosis of pheochromocytoma, was unexpectedly found to suffer from medullary carcinoma of the thyroid. Prior to performing the test, we proceeded to block uptake into the thyroid gland through the administration of Lugol. We carried out the scintigraphic study by intravenously injecting 370 MBq 123I-MIBG. RESULTS: A pathological uptake of the radiopharmaceutical compound over the right suprarenal gland, and unexpectedly, over the thyroid gland was detected, thus confirming the existence of medullary carcinoma of the thyroid in this patient, and obtaining the diagnosis of Type MEN2A polyglandular syndrome. CONCLUSIONS: From our experience, we can manifest the value of scintigraphy using 123I-MIBG in the diagnosis and localization of medullary carcinoma of the thyroid. Furthermore, it is indicated in patients suspected of MEN, since it makes it possible to reach a diagnosis of this kind of syndrome through the performance of just one test.